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Intranuclear coinjection of the late SV40 KpnI/Bcn DNA fragment and the early promoter/enhancer 
HpaII/Bgfi DNA segment into permissive monkey and non-permissive mouse cells allows late SV40 gene 
expression without T-antigen synthesis and DNA replication. These conditions were chosen to analyse the 
effect of DNA methylation on V-antigen synthesis detached from the process of DNA replication. We 
found that in vitro methylation of a single cytosine nucleotide proximal to the major late mRNA cap site 
by the HpaII methylase does not block capsid protein synthesis. This result is in contrast to reported data 
obtained in Xenopus luevis oocyte injection experiments [(1982) Proc. Natl. Acad. Sci. USA 79, 
5142-51461. 
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1. INTRODUCTION frog oocytes V-antigen synthesis eems to occur in 
a manner independent of DNA replication [I]. 
Authors in [l] recently reported that DNA 
methylation inhibits the expression of SV40 genes. 
They found that methylation of a single cytosine 
nucleotide at the late SV40 map position 0.725 by 
&a11 methylase blocked the synthesis of the cap- 
sid proteins (V-antigen) after microinjection of 
DNA into Xenopus oocytes fl]. We showed in [2] 
that complete methylation of SV40 and polyoma 
virus (PV) DNA by either the Wp&I or rat liver 
methylase did not affect the biological activity of 
these viral DNAs. When microinjected into 
cultured mouse and monkey cells, T-antigen syn- 
thesis, viral DNA replication and synthesis of V- 
antigen occurred with the same efficiency with 
both methylated and unmethylated DNAs [2]. We 
have thus proven that expression of the early SV40 
and PV genes as well as viral DNA replication are 
methylation-insensitive. In view of the fact that 
DNA replication causes demethylation of injected 
DNA, nothing coutd be said about the 
methyIation-insensitivity of late viral gene expres- 
sion which depends on the replication step [2]. In 
We describe here conditions in which expression 
of late SV40 genes is obtained in the absence of 
viral DNA replication, SV40 capsid protein syn- 
thesis is induced efficiently by coinjection of the 
late promoter-free KpnI/Bgfl DNA fragment 
[3,4], and the early SV40 ‘promoter/enhancer’ 
HpaII/Bgfl DNA fragment t5] regardless of 
whether the KpnI/Bc/I fragment was methylated 
by the HpaII enzyme. About 20 h after the 
microinjection, 20-309’0 of the recipient cells syn- 
thesized V-antigen even when DNA synthesis was 
blocked by ara C. Thus methylation of the WpaII 
site does not prevent late SV40 gene expression in 
mammalian cells, unlike the situation reported for 
Xenopus iaevis oocytes. 
2. MATERIALS AND METHODS 
2.1. Cell culture and microinjection 
For all ex~riments TC7 cells, a subline of the 
CVl line of African green monkey kidney cells and 
primary mouse kidney cells isolated from newborn 
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NMRI mice were used. Cells were grown in 
Dulbecco’s modified Eagle medium supplemented 
with 5% fetal calf serum (Gibco Europe). Details 
of the microinjection technique are described 
elsewhere [6]. 
2.2. Methylation of SV40 DNA and preparation 
of DNA fragments 
Forty pg SV40 DNA were incubated with 400 
units HpaII methylase (Bio Labs New England) in 
100~1 reaction buffer containing 50 mM 
Tris-HCl (pH 7.9, 10 mM EDTA, 80pM S- 
adenosylmethionine (Sigma) and 5 mM 2-mercap- 
toethanol at 37°C for 16 h. After incubation the 
reaction mixture was treated twice with 0.5% SDS 
and Tris-HCl (pH 7.0) saturated phenol. DNA 
was precipitated from the aqueous phase with 
ethanol. Completion of methylation was checked 
by incubation of the DNA with HpaII and MspI 
endonucleases as in [2]. To remove further any 
contaminating amounts of unmethylated DNA, 
the preparation was cleaved by HpaII and Bcfl 
enzyme treatment. Under these conditions 
methylated DNA is converted into DNA III and 
unmethylated DNA into two fragments (see fig. 1). 
After isolation from the agarose gel (1 ‘?‘o), DNA 
III was further incubated with KpnI and TaqI en- 
donucleases. The reaction mixture was elec- 
trophoresed and the KpnI/BclI DNA-A fragment 
isolated from the gel and dissolvd in 10 mM 
Tris-HCl (pH 7.4) buffer at a concentration of 
0.2 pg/lO ~1. The HpaII/Bgfl fragment cloned in 
the Sal site of pBR322 was liberated from the 
plasmid DNA by Sa/I digestion and purified by 
agarose gel electrophoresis. For microinjection 
KpnI/BclI and HpaII/BglI fragments were mixed 
at a concentration of 0.1 pg/lO ,J each in 
Tris-HCl (pH 7.4). 
3. RESULTS 
As shown in fig. 1, the KpnI/BclI fragment (map 
position 0.715-0.189) of SV40 DNA contains the 
late coding region and the HpaII site at the map 
position 0.725. This fragment was microinjected 
into the nuclei of both permissive monkey cells 
(TC7) and non-permissive mouse cells (primary 
mouse kidney cells) cultured in vitro. At different 
times after the injection (12, 24 and 36 h), cells 
were fixed and none stained positive for either T- 
152 
0 + I late 1 
HpaII BglI KpnI BclI 
Fig. 1. Transcription map and the early control region of 
SV40. The arrow-headed circles around the SV40 
genome indicate the localisation and orientation of the 
early and late transcripts (spliced regions not indicated). 
The localisation of the two 72-bp enhancers and the three 
21-bp repeats as well as the AT-rich sequence (TATA- 
box) within the HpaII/BglI DNA fragment are shown 
schematically. The bottom part shows the two SV40 
DNA fragments used for microinjection. 
or V-antigen as expected [3,4]. 
The SV40 DNA HpaII/Bgfi fragment (map 
position 0.725-0.661) contains the early pro- 
motor/enhancer egion; the cap site for early SV40 
mRNA is distal to the Bgfl site [5]. When this frag- 
ment is coinjected with the promotor-minus 
KpnI/BclI fragment of SV40, synthesis of V-an- 
tigen results (fig.2). In this experiment, fragments 
were only mixed in the injection buffer at 
0.01 mg/ml each and in vitro ligation was found to 
be unnecessary. We found from DNA reextraction 
experiments and blot analysis that coligation of 
these fragments occurs immediately after the injec- 
tion inside the recipient cell (in preparation). 
Following coinjection of these fragments, V-an- 
tigen positive cells were first demonstrable within 
6-8 h and that about 25-30% of the cells ex- 
hibited a strong intranuclear V-antigen fluo- 
rescence 20 h after injection (table l), while T- 
antigen synthesis could not be shown. 
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Fig.2. Immunofluorescence staining of microinjected 
TC7 cells. (1) V-antigen positive cells microinjected with 
the KpnI/BclI + HpaII/BglI fragment mixture. (2) The 
same cells stained for T-antigen. (3) V-antigen positive 
cells after microinjection of the methylated KpnI/BcfI 
and HpaII/BgfI promoter/enhancer f agment. Cells 
were fixed and stained 24 h after microinjection. 
To ascertain whether inhibitors of DNA replica- 
tion affect the synthesis of V-antigen, ara C was 
added to the medium (final cont. 40pg/ml) 2 h 
prior to the injection and maintained throughout 
the culture period. We again found that in these 
conditions V-antigen synthesis occurred (table 1) 
as in the absence of ara C. 
To determine whether methylation of the 
KpnI/Bc/I fragment blocks V-antigen synthesis, 
SV40 DNA I was methylated by exhaustive treat- 
ment with H’aII methylase. To remove possible 
trace amounts of unmethylated molecules, this 
DNA was further incubated with NpaII and &/I 
endonucleases, electrophoresed in agarose and 
SV40 form III DNA was eluted from the gel. This 
DNA was then digested with KpnI restriction en- 
donuclease, reelectrophoresed in agarose and the 
KpnI/Bc/I methylated fragment was then coin- 
jetted with early SV40 promoter/enhancer DNA 
fragment. Again we found that V-antigen synthesis 
occurred with the same efficiency as in the ex- 
periments using the unmethylated KpnI/BclI DNA 
fragment, and that ara C did not prevent V-antigen 
synthesis under these conditions (table 1). 
4. DISCUSSION 
The biological significance of DNA methylation 
is still an open question although some of the ex- 
periments do indicate that methylation may be in- 
volved in the regulation of gene expression in 
eukaryotes. This is based on the observation that 
many active genes are less methylated than their in- 
active counterparts. More direct evidence support- 
ing the hypothesis that DNA methylation in- 
fluences gene expression has come from DNA 
transfection and microinjection experiments how- 
ing that the biological activity of methylated DNA 
is significantly lower than the unmethylated form 
when transferred to cultured mammalian cells or 
frog oocytes (review [7]). 
Data exist which do not support such a 
generalization. For example, authors in [8] have 
shown that activation of the H2K gene(s) in 
teratocarcinoma cells is correlated with increased 
DNA methylation. Similarly, we have shown that 
complete methylation of SV40 and PV DNA does 
not affect the expression of early genes as well as 
viral DNA replication [2]. Here, we further show 
that methylation of the NpaII position in the 
KpnI/Bcfl fragment of SV40 DNA containing the 
late coding region in no way affects the expression 
of V-antigen. Considering our data as well as those 
of others, we postulate that if DNA methylation is 
involved in the regulation of eukaryotic gene ex- 
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Table 1 
Biological activity of the methylated and unmethylated SV40 KpnI/Bcll DNA fragment 
Injection of Antigen formation (070) 
Monkey cells Mouse cells 
T V T V 
SV40 DNA 1’ 99 99 99 00 
SV40 DNA I (ara C) 99 00 99 00 
SV40 DNA fragments: 
KpnI/Bcn 00 00 00 00 
HpaWBgiI 00 00 NT NT 
KpnI/BclI + HpaII/Bgll 00 25-30 00 25-30 
KpnI/BcZI + HpaWBgn (ara C) 00 25-30 NT NT 
KpnI/3cnmethy’. + HpaII/BglI 00 25-30 00 25-30 
KpnI/BclImethy’~ + HpaWBgiI 
(ara C) 00 25-30 00 25-30 
a In these experiments the SV40 DNA I concentration was 0.05 mg/ml injection buffer 
NT, not tested. Cells were fixed and stained for T- and V-antigen 20 h after microinjection 
by the indirect immunofluorescen~e t chnique 
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pression, then there must be at least two categories 
of genes, one of which is methylation-insensitive 
and the other methylation-sensitive. This clearly 
raises the question as to the nature of the dif- 
ference between these two categories at least in 
terms of the site specificity for methylation- 
effectiveness. Analysis of the methylatable sites 
(CG) of SV40 and PV DNA and their distribution 
within the putative promoter/enhancer region of 
viral DNAs has shown that the CG dinucleotide se- 
quence is not under-represented in this region as 
compared to the genes which have been reported to 
be methylation-sensitive. Of the 27 CG dinucleo- 
tides in the SV40 genome, 19 are located within the 
early promotor region. Similarly, 23 out of 96 such 
dinucleotides are in the promotor region of the PV 
genome [9]. This implies that methylation-sen- 
sitivity is not determined by the absolute number 
of CG but, rather, by a specific position within the 
gepe. This implication is well supported by the 
report [l] that methylation of a single cytosine 
nucleotide distal to the late mRNA cap site blocked 
synthesis of the SV40 capsid proteins in frog 
oocytes. We have shown here that methylation of 
this specific site by the HpaII methylase does not 
impart methylation-sensitivity for the expression 
of V-antigen to either permissive monkey cells or 
non-per~ssive mouse cells. 
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